Asahi Life Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Asahi Life Asset Management's GILD Position: Q2 2026 in Review
Asahi Life Asset Management sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 2,062 shares — an estimated $287K sold.
Asahi Life Asset Management first reported a position in GILD in Q4 2018 and held it in 17 quarters. The position peaked at $2.3M in Q3 2019. 2,292 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Asahi Life Asset Management reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
- Asahi Life Asset Management sold 2,062 Gilead Sciences shares in Q2 2026, an estimated $287K.
- Asahi Life Asset Management first reported a position in Gilead Sciences in Q4 2018 and held it in 17 quarters.
- Asahi Life Asset Management's Gilead Sciences position peaked at $2.3M in Q3 2019.
- 2,292 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Asahi Life Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.